CCCC
Price
$1.68
Change
+$0.05 (+3.09%)
Updated
Jun 13, 04:59 PM (EDT)
Capitalization
115.03M
54 days until earnings call
PRME
Price
$1.47
Change
+$0.01 (+0.68%)
Updated
Jun 13, 04:59 PM (EDT)
Capitalization
191.69M
54 days until earnings call
Interact to see
Advertisement

CCCC vs PRME

Header iconCCCC vs PRME Comparison
Open Charts CCCC vs PRMEBanner chart's image
C4 Therapeutics
Price$1.68
Change+$0.05 (+3.09%)
Volume$6.45K
Capitalization115.03M
Prime Medicine
Price$1.47
Change+$0.01 (+0.68%)
Volume$9.97K
Capitalization191.69M
CCCC vs PRME Comparison Chart
Loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. PRME commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and PRME is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2025
Stock price -- (CCCC: $1.62 vs. PRME: $1.46)
Brand notoriety: CCCC and PRME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 106% vs. PRME: 49%
Market capitalization -- CCCC: $115.03M vs. PRME: $191.69M
CCCC [@Biotechnology] is valued at $115.03M. PRME’s [@Biotechnology] market capitalization is $191.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $352B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whilePRME’s FA Score has 0 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • PRME’s FA Score: 0 green, 5 red.
According to our system of comparison, PRME is a better buy in the long-term than CCCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 4 TA indicator(s) are bullish while PRME’s TA Score has 5 bullish TA indicator(s).

  • CCCC’s TA Score: 4 bullish, 4 bearish.
  • PRME’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PRME is a better buy in the short-term than CCCC.

Price Growth

CCCC (@Biotechnology) experienced а +10.20% price change this week, while PRME (@Biotechnology) price change was +7.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.83%. For the same industry, the average monthly price growth was +19.99%, and the average quarterly price growth was +6.61%.

Reported Earning Dates

CCCC is expected to report earnings on Aug 06, 2025.

PRME is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRME($192M) has a higher market cap than CCCC($115M). PRME YTD gains are higher at: -50.000 vs. CCCC (-55.000). CCCC has higher annual earnings (EBITDA): -102.74M vs. PRME (-200M). CCCC has more cash in the bank: 215M vs. PRME (144M). CCCC has less debt than PRME: CCCC (64.4M) vs PRME (121M). CCCC has higher revenues than PRME: CCCC (39.8M) vs PRME (3.85M).
CCCCPRMECCCC / PRME
Capitalization115M192M60%
EBITDA-102.74M-200M51%
Gain YTD-55.000-50.000110%
P/E RatioN/AN/A-
Revenue39.8M3.85M1,035%
Total Cash215M144M149%
Total Debt64.4M121M53%
FUNDAMENTALS RATINGS
PRME: Fundamental Ratings
PRME
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CCCCPRME
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
N/A
Bullish Trend 29 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSAZX28.190.17
+0.61%
Invesco Main Street All Cap R5
CAMLX47.340.14
+0.30%
Congress Large Cap Growth Retail
APAYX10.880.03
+0.28%
Integrity Dividend Summit A
CSDGX15.240.02
+0.13%
Copeland SMID Cap Dividend Growth A
DEMAX24.65-0.02
-0.08%
Macquarie Emerging Markets A

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with KYMR. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
+6.58%
KYMR - CCCC
57%
Loosely correlated
-2.27%
CRBU - CCCC
57%
Loosely correlated
-1.69%
BEAM - CCCC
54%
Loosely correlated
-2.52%
FATE - CCCC
53%
Loosely correlated
-9.68%
ATXS - CCCC
51%
Loosely correlated
-3.28%
More

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been loosely correlated with CRSP. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
-4.58%
CRSP - PRME
63%
Loosely correlated
-0.58%
RXRX - PRME
55%
Loosely correlated
-4.26%
BEAM - PRME
54%
Loosely correlated
-2.52%
CCCC - PRME
51%
Loosely correlated
+6.58%
CRBU - PRME
50%
Loosely correlated
-1.69%
More